等待开盘 02-06 09:30:00 美东时间
-2.580
-5.51%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Scholar Rock Holding Corporation : H.c. Wainwright Raises Target Price to $58 F...
01-26 19:10
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
Scholar Rock Chief Scientific Officer Mo Qatanani Reports Sale of Common Shares Mo Qatanani, Chief Scientific Officer, reported a disposal of common shares of Scholar Rock Holding Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public T
01-22 08:52
CHRO Caryn Parlavecchio Reports Sale of Scholar Rock Holding Corporation Common Shares Caryn Parlavecchio, Chief Human Resources Officer of Scholar Rock Holding Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This
01-22 08:52
Scholar Rock Chief Medical Officer Jing L. Marantz Reports Sale of Common Shares Jing L. Marantz, Chief Medical Officer of Scholar Rock Holding Corporation, reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below.
01-22 08:51
Scholar Rock General Counsel Junlin Ho Reports Sale of Common Shares Junlin Ho, General Counsel of Scholar Rock Holding Corporation, reported a disposal of common shares of Scholar Rock Holding Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was creat
01-22 08:50
Scholar Rock Holding ( ($SRRK) ) has provided an announcement. On January 12, 2...
01-12 22:58
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33